Class 2 medicines recall: Sanofi Fasturtec 7.5 mg, 1.5 mg/ml powder and solvent for concentrate for solution for infusion

Sanofi has informed the Medicines and Healthcare products Regulatory Agency (MHRA) that it is recalling batch number A9306 of Fasturtec 7.5 mg, 1.5 mg/ml powder and solvent for concentrate for solution for infusion. This is as a precautionary measure due to an out of specification result detected for rasburicase enzyme activity according to a specific method and specifications for US market, at 12 months stability time point.

Further information including advice for healthcare professionals can be found on the MHRA website.